SCA
WST icon

Secor Capital Advisors’s West Pharmaceutical WST Stock Holding History

Secor Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,573
Closed -$2.04M – 557
2017
Q2 		$2.04M Buy
+21,573
New +$1.98M 0.19% 179
2014
Q2 		– Sell
-48,977
Closed -$2.16M – 323
2014
Q1 		$2.16M Buy
+48,977
New +$2.31M 1.06% 4

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Secor Capital Advisors's WST Position: Q3 2017 in Review

Secor Capital Advisors sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 21,573 shares — an estimated $2.04M sold.

Secor Capital Advisors first reported a position in WST in Q1 2014 and held it in 2 quarters. The position peaked at $2.16M in Q1 2014. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Secor Capital Advisors reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 21,573 West Pharmaceutical shares in Q3 2017, an estimated $2.04M.
  • Secor Capital Advisors first reported a position in West Pharmaceutical in Q1 2014 and held it in 2 quarters.
  • Secor Capital Advisors's West Pharmaceutical position peaked at $2.16M in Q1 2014.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Secor Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.